Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 722-729

  Inagaki, Takayuki ^a,b,c   Yagi, Tetsuya ^d   Ichikawa, Kazuya ^a   Nakagawa, Taku ^a   Moriyama, Makoto ^a,e   Uchiya, Kei Ichi ^b   Nikai, Toshiaki ^b   Ogawa, Kenji ^a  

^a Meito ku   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c Takayama Red Cross Hospital   (Japan)

^d NAGOYA UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

23S rRNA; Amplification refractory mutation system PCR method; Drug susceptibility test

Indexed keywords

CLARITHROMYCIN; RNA 23S;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; NONHUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WILD TYPE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TUBERCULOSIS;

EID: 79952802683     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq536     Document Type: Article

References (30)

1. Dautzenberg B, Truffot C, Legris S et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis 1991; 144: 564-9.
2. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
3. National Committee for Clinical Laboratory Standards. Susceptibility Testing for Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
4. Testoni PA, Bagnolo F, Colombo E et al. The correlation in dyspeptic patients of Helicobacter pylori infection with changes in interdigestive gastroduodenal motility patterns but not in gastric emptying. Helicobacter 1996; 1: 229-37.
5. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45: 1-12.
6. Pfister P, Corti N, Hobbie S et al. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G. Proc Natl Acad Sci USA 2005; 102: 5180-5.
7. Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995; 39: 2625-30.
8. Meier A, Heifets L, Wallace RJ Jr et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 1996; 174: 354-60.
9. Jamal MA, Maeda S, Nakata N et al. Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. Tuber Lung Dis 2000; 80: 1-4.
10. Griffith DE, Brown-Elliott BA, Langsjoen B et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006; 174: 928-34.
11. Meier A, Kirschner P, Springer B et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 1994; 38: 381-4.
12. Wallace RJ Jr, Meier A, Brown BA et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996; 40: 1676-81.
13. Burman WJ, Stone BL, Brown BA et al. AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Diagn Microbiol Infect Dis 1998; 31: 369-71.
14. Katila ML, Katila P, Erkinjuntti-Pekkanen R. Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems. J Clin Microbiol 2000; 38: 960-4.
15. Kawata N, Kawahara S, Tada A et al. Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM. Kekkaku 2006; 81: 329-35.
16. Kobayashi I, Murakami K, Kato M et al. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol 2007; 45: 4006-10.
17. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-85.
18. van Doorn LJ, Debets-Ossenkopp YJ, Marais A et al. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 1999; 43: 1779-82.
19. van der Ende A, van Doorn LJ, Rooijakkers S et al. Clarithromycin-susceptible and-resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol 2001; 39: 2648-51.
20. van doorn LJ, Glupczynski Y, Kusters JG et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001; 45: 1500-4.
21. Mäkinen J, Marttila HJ, Marjamäki M et al. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-2.
22. Cavusoglu C, Turhan A, Akinci P et al. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 2338-42.
23. Wada T, Maeda S, Tamaru A et al. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2004; 42: 5277-85.
24. Nakamura A, Furuta T, Shirai N et al. Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method. J Gastroenterol Hepatol 2007; 22: 1057-63.
25. Furuta T, Soya Y, Sugimoto M et al. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin. J Gastroenterol Hepatol 2007; 22: 1810-5.
26. Higuchi T, Fushiwaki T, Tanaka N et al. Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA). Kekkaku 2004; 79: 525-30.
27. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol 2003; 41: 2616-22.
28. Ikeda S, Takabe K, Inagaki M et al. Detection of gene point mutation in paraffin sections using in situ loop-mediated isothermal amplification. Pathol Int 2007; 57: 594-9.
29. Yoshida S, Suzuki K, Tsuyuguchi K et al. Evaluation of the discrepant Mycobacterium tuberculosis strains between any ordinary susceptibility testing and rpoB gene analysis by the line probe assay. Kekkaku 2008; 83: 577-83.
30. Hillemann D, Weizenegger M, Kubica T et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-703.